Dr. D. Vergani

Dr. D. Vergani's AcademicInfluence.com Rankings

Dr. D. Vergani

Philosophy

#5118

World Rank

#7844

Historical Rank

Logic

#2448

World Rank

#3441

Historical Rank

philosophy Degrees

Dr. D. Vergani

Biology

#6820

World Rank

#9621

Historical Rank

Immunology

#356

World Rank

#370

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Dr. D. Vergani's Degrees

Doctorate Medicine University of California, San Francisco
PhD Immunology Stanford University

Why Is Dr. D. Vergani Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dr. D. Vergani's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis and management of autoimmune hepatitis (2010) (779)
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16‐year prospective study (2001) (596)
Autoimmune hepatitis in childhood: A 20‐year experience (1997) (588)
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. (2000) (552)
The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection (2000) (438)
Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms (2000) (420)
Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? (1990) (417)
INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B (1982) (405)
Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. (2004) (385)
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. (2004) (363)
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. (1999) (361)
Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. (1982) (356)
Functional Study of CD4+CD25+ Regulatory T Cells in Health and Autoimmune Hepatitis1 (2006) (306)
The importance of immune dysfunction in determining outcome in acute liver failure. (2008) (281)
Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. (1980) (248)
Aetiopathogenesis of autoimmune hepatitis. (2010) (244)
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease (2002) (243)
Autoimmune hepatitis--Update 2015. (2015) (242)
Source and characterization of hepatic macrophages in acetaminophen‐induced acute liver failure in humans (2012) (237)
Pathogenesis of autoimmune hepatitis. (2011) (234)
Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions. (2015) (225)
De-novo autoimmune hepatitis after liver transplantation (1998) (214)
Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity (1991) (214)
Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. (2005) (208)
Autoimmune liver serology: current diagnostic and clinical challenges. (2008) (187)
Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. (2006) (178)
Autoimmune hepatitis: a comprehensive review. (2013) (175)
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis (2010) (172)
The increasing prevalence of hepatitis delta virus (HDV) infection in South London (2008) (169)
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM (1996) (162)
CD14, CD16 and HLA‐DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA‐DR expression by CD14hi/CD16neg monocytes: Expansion of CD14hi/CD16pos and contraction of CD14lo/CD16pos monocytes in acute liver failure (2012) (162)
Autoimmune hepatitis (2018) (160)
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. (2001) (159)
Cytochrome P4502D6193–212: A New Immunodominant Epitope and Target of Virus/Self Cross-Reactivity in Liver Kidney Microsomal Autoantibody Type 1-Positive Liver Disease 1 (2003) (154)
Reduced monocyte HLA‐DR expression: A novel biomarker of disease severity and outcome in acetaminophen‐induced acute liver failure (2006) (152)
Dysfunctional CD39POS regulatory T cells and aberrant control of T‐helper type 17 cells in autoimmune hepatitis (2014) (145)
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. (2004) (138)
Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. (1986) (137)
Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement. (2018) (132)
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis (2005) (128)
Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion. (2001) (127)
The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin‐9/tim‐3 pathway (2012) (125)
Cytochrome P450IID6‐specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2 (2007) (124)
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. (2010) (123)
Autoimmune hepatitis in children: what is different from adult AIH? (2009) (122)
Autoantibodies and their antigens in autoimmune hepatitis. (2009) (121)
GENETICALLY DETERMINED LOW C4: A PREDISPOSING FACTOR TO AUTOIMMUNE CHRONIC ACTIVE HEPATITIS (1985) (119)
Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy (2003) (117)
Primary biliary cirrhosis is characterized by IgG3 antibodies cross‐reactive with the major mitochondrial autoepitope and its Lactobacillus mimic (2005) (115)
HCV infection: pathogenesis, clinical manifestations and therapy. (2008) (112)
Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis (2008) (112)
T cell activation and disease severity in HIV infection (1993) (111)
Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection (1998) (110)
Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review. (2013) (107)
Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. (1979) (107)
Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study. (2006) (106)
Class I and class II major histocompatibility complex antigen expression on hepatocytes: A study in children with liver disease (1990) (105)
Autoimmune paediatric liver disease. (2008) (104)
Diagnostic criteria of autoimmune hepatitis. (2014) (103)
Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. (1992) (101)
Antimitochondrial and other autoantibodies. (2003) (100)
The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. (2007) (99)
Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis. (2012) (99)
Autoantigen‐specific regulatory T cells, a potential tool for immune‐tolerance reconstitution in type‐2 autoimmune hepatitis (2011) (99)
Serial circulating markers of inflammation in biliary atresia—Evolution of the post‐operative inflammatory process (2007) (96)
PATHOGENESIS OF INSULIN-DEPENDENT DIABETES: A ROLE FOR ACTIVATED T LYMPHOCYTES (1984) (96)
Cutting edge issues in autoimmune hepatitis. (2016) (96)
Treatment challenges and investigational opportunities in autoimmune hepatitis (2005) (93)
De-novo autoimmune hepatitis after liver transplantation. (1998) (90)
Update on Autoimmune Hepatitis (2015) (90)
T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis (1990) (89)
Multiple Viral/Self Immunological Cross-Reactivity in Liver Kidney Microsomal Antibody Positive Hepatitis C Virus-Infected Patients is Associated with the Possession of HLA B51 (2004) (89)
Major histocompatibility complex associations with primary antiphospholipid syndrome. (1992) (88)
Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments (2017) (85)
Organ and Non-organ Specific Autoantibody Titres and IgG Levels as Markers of Disease Activity: A Longitudinal Study in Childhood Autoimmune Liver Disease (2002) (83)
Bacteria and Primary Biliary Cirrhosis (2009) (83)
Clinical significance of autoantibodies in autoimmune hepatitis. (2013) (82)
Virus, liver and autoimmunity. (2000) (80)
Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. (1995) (80)
A novel “humanized mouse” model for autoimmune hepatitis and the association of gut microbiota with liver inflammation (2015) (76)
Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus. (1994) (76)
Secretory leukocyte protease inhibitor: A pivotal mediator of anti‐inflammatory responses in acetaminophen‐induced acute liver failure (2014) (75)
In autoimmune hepatitis type 1 or the autoimmune hepatitis–sclerosing cholangitis variant defective regulatory T‐cell responsiveness to IL‐2 results in low IL‐10 production and impaired suppression (2015) (74)
Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage. (2008) (74)
Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T‐cells (2009) (74)
Key Residues of a Major Cytochrome P4502D6 Epitope Are Located on the Surface of the Molecule1 (2002) (73)
Liver transplantation and autoimmune liver diseases (2013) (73)
New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. (2009) (72)
Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures (1997) (72)
Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. (1996) (72)
Autoimmune liver diseases in children - what is different from adulthood? (2011) (72)
Cytokine overproduction in healthy first degree relatives of patients with IDDM (1998) (71)
Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern Chinese. (1992) (70)
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. (2001) (70)
Admission levels and early changes in serum interleukin‐10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis (2010) (69)
The challenges of primary biliary cholangitis: What is new and what needs to be done. (2019) (68)
Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood (1989) (68)
Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. (1997) (66)
Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda (2018) (66)
Immune changes associated with insulin dependent diabetes may remit without causing the disease: a study in identical twins. (1986) (66)
Diagnosis and Management of Paediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement. (2017) (66)
Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. (2001) (65)
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? (2003) (65)
Susceptibility to thyroid disorders in hepatitis C. (2005) (65)
Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. (2003) (64)
Autoantibody prevalence in chronic hepatitis B virus infection: Effect in interferon alfa (1996) (64)
Role of monocytes and macrophages in experimental and human acute liver failure. (2010) (64)
Autoimmunity after liver transplantation (2002) (63)
Autoimmune manifestations in viral hepatitis (2012) (63)
A Study of Molecular Mimicry and Immunological Cross-reactivity between Hepatitis B Surface Antigen and Myelin Mimics (2005) (63)
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis (2007) (61)
Autoimmunity and Environment: Am I at risk? (2012) (61)
The value of complement activation products in the assessment of systemic lupus erythematosus flares. (1995) (61)
HCV and autoimmunity. (2008) (60)
Immune and Viral Profile from Tolerance to Hepatitis B Surface Antigen Clearance: a Longitudinal Study of Vertically Hepatitis B Virus-Infected Children on Combined Therapy (2010) (60)
Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone. (1994) (60)
Pathogenesis of autoimmune hepatitis. (2002) (60)
Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. (2004) (60)
Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity. (1990) (59)
Immune factors in narcolepsy. (1986) (59)
Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis (2011) (57)
Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection (1994) (57)
Anti‐liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease (1995) (57)
Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis. (1994) (56)
Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease (2015) (56)
Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes? (1983) (56)
Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross‐reactivity (2004) (55)
Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity. (1982) (55)
Clinical application of a new nephelometric technique to measure complement activation. (1983) (55)
Anti‐gp210 antibody mirrors disease severity in primary biliary cirrhosis (2007) (53)
Proteinuria and Activated T-Lymphocytes in Diabetic Nephropathy (1988) (53)
Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. (2008) (52)
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity? (2021) (52)
HISTOLOGICAL EVIDENCE OF HEPATITIS-B-VIRUS INFECTION WITH NEGATIVE SEROLOGY IN CHILDREN WITH ACUTE LEUKAEMIA WHO DEVELOP CHRONIC LIVER DISEASE (1982) (52)
Aetiopathogenesis of autoimmune hepatitis. (2008) (51)
Activation of the complement system in systemic sclerosis. Relationship to clinical severity. (1989) (51)
Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis. (1987) (51)
Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection. (1997) (51)
Circulating levels of mannose binding protein in human immunodeficiency virus infection. (1995) (50)
Elevation of activated γδ T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease (1992) (49)
IgG subclass deficiency in asthma. (1988) (49)
Activation of the complement system in primary sclerosing cholangitis. (1989) (49)
Increase in Simultaneous Coexpression of Naive and Memory Lymphocyte Markers at Diagnosis of IDDM (1993) (49)
Cellular expression of tumour necrosis factor-α and interferon-γ in the liver biopsies of children with chronic liver disease (1994) (49)
Th-17 cells infiltrate the liver in human biliary atresia and are related to surgical outcome. (2015) (47)
Class I and class II major histocompatibility complex antigens on hepatocytes: importance of the method of detection and expression in histologically normal and diseased livers. (1991) (47)
Pharmacological management of autoimmune hepatitis (2011) (47)
Detection of Potentially Reversible Diabetic Albuminuria: A Three-drop Agglutination Test for Urinary Albumin at Low Concentration (1982) (46)
Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease. (1982) (46)
Chronic liver disease in children with leukemia in long‐term remission (1983) (46)
Graft-versus-host disease after orthotopic liver transplantation in a child. (1990) (45)
Basic and clinical immunology (1997) (45)
Type II autoimmune hepatitis. What is the role of the hepatitis C virus? (1993) (45)
Unique features of primary sclerosing cholangitis in children (2010) (44)
Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway. (1989) (44)
Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. (1998) (44)
Spontaneous bacterial peritonitis in children with chronic liver disease: clinical features and etiologic factors. (1985) (44)
Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus. (1988) (43)
The Role of E. coli Infection in the Pathogenesis of Primary Biliary Cirrhosis (2011) (43)
Analysis of lymphocyte phenotypes in cord blood from early gestation fetuses (1992) (42)
Cell cycling in HIV infection: analysis of in vivo activated lymphocytes (1995) (41)
A 12-year-old girl with antimitochondrial antibody-positive autoimmune hepatitis. (1997) (41)
Paralysed monocytes in acute on chronic liver disease. (2005) (40)
Autoimmune hepatitis. (2009) (40)
T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile. (2013) (39)
Sclerosing Cholangitis in Children and Adolescents. (2016) (39)
SENSITISATION TO HALOTHANE-ALTERED LIVER COMPONENTS IN SEVERE HEPATIC NECROSIS AFTER HALOTHANE ANÆSTHESIA (1978) (39)
Paediatric Autoimmune Liver Disease (2015) (39)
Unusual suspects in primary biliary cirrhosis (2004) (39)
Sensitisation to Halothane-Altered Liver Components in Severe Hepatic Necrosis after Halothane Anaesthesia (1979) (38)
Paediatric autoimmune liver disease (2013) (38)
Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. (2012) (37)
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. (2007) (37)
Autoimmune hepatitis after liver transplantation. (2012) (37)
Reduction of complement activation during bypass by prime manipulation. (1990) (36)
Non-organ-specific autoantibodies in children with chronic hepatitis C virus infection. (2004) (36)
Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease. (1997) (36)
Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus. (1991) (36)
Effect of fresh frozen plasma and gammaglobulin on humoral immunity in neonatal sepsis. (1994) (36)
CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease. (2016) (36)
Actin‐free Gc globulin: A rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis (2007) (36)
Immunological cross‐reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis (1998) (35)
Hepatic damage after exposure to halothane in medical personnel. (1981) (35)
AASLD PRACTICE GUIDELINES Diagnosis and Management of Autoimmune Hepatitis (2010) (35)
Regulatory T‐cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis (2017) (35)
Evidence that the reduced number of natural killer cells in Type 1 (insulin-dependent) diabetes may be genetically determined (1987) (35)
Origin of cross‐reactive autoimmunity in primary biliary cirrhosis (2006) (35)
Antibodies to the Surface of Halothane-Altered Rabbit Hepatocytes in Patients with Severe Halothane-Associated Hepatitis (1981) (35)
Pathways to complement activation during cardiopulmonary bypass. (1984) (34)
Immunological liver diseases in children. (1998) (34)
High Prevalence of Autoantibodies to Glutamic Acid Decarboxylase in Long-Standing IDDM Is Not a Marker of Symptomatic Autonomic Neuropathy (1994) (34)
Serology in autoimmune hepatitis: A clinical-practice approach. (2017) (33)
Immunodeficiency‐related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry (2002) (33)
Autoimmune liver disease serology in acute hepatitis E virus infection. (2018) (33)
Complement activation before, during and after cardiopulmonary bypass. (1990) (33)
Progress in pediatric autoimmune hepatitis. (1994) (33)
Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2. (2014) (32)
Alterations in T-Lymphocyte Subpopulations in Type I Diabetes: Exploration of Genetic Influence in Identical Twins (1988) (32)
Regulatory T cells in autoimmune hepatitis. (2012) (32)
Alcohol dehydrogenase–specific T‐cell responses are associated with alcohol consumption in patients with alcohol‐related cirrhosis (2013) (32)
Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope. (2001) (31)
Human CD4+CD25(high)CD127 (low/neg) regulatory T cells. (2012) (31)
Identification of biliary antigens in circulating immune complexes in primary biliary cirrhosis. (1980) (31)
Diabetes and Autonomic Neuropathy: An Immunological Association? (1986) (31)
High prevalence of food sensitisation in young children with liver disease: a clue to food allergy pathogenesis? (2012) (31)
Positive markers in AMA-negative PBC. (2003) (30)
Clinical correlation between diabetic and non diabetic patients with myocardial infarction. (1991) (30)
Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins (1994) (30)
Autoimmune hepatitis (2011) (30)
Autoimmune chronic active hepatitis in a family. (1991) (30)
Prevalence of autoantibodies to autonomic nervous tissue structures in Type 1 diabetes mellitus (1999) (29)
The role of HBV DNA quantitative PCR in monitoring the response to interferon treatment in chronic hepatitis B virus infection. (1999) (29)
Sclerosing cholangitis in the paediatric patient. (2001) (29)
Isopropylation of biphenyl over dealuminated mordenite (1997) (28)
Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection. (1994) (28)
Case against subclassification of type II autoimmune chronic active hepatitis (1993) (28)
The Role ofE. coliInfection in the Pathogenesis of Primary Biliary Cirrhosis (2010) (28)
Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality. (1988) (28)
MHC molecular mimicry in diabetes (1995) (28)
Budesonide for juvenile autoimmune hepatitis? Not yet. (2013) (28)
Sclerosing Cholangitis With Granulocytic Epithelial Lesion: A Benign Form of Sclerosing Cholangiopathy (2012) (27)
Autoimmune hepatitis: From mechanisms to therapy. (2016) (27)
Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter? (2005) (27)
Mechanisms of autoimmune hepatitis (2004) (27)
Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal? (1989) (27)
Quantification of C3d in biological fluids by an enzyme-linked immunosorbent assay. (1987) (27)
De novo autoimmune hepatitis -is this different in adults compared to children? (2018) (26)
The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. (2018) (26)
IgM reduction in systemic lupus erythematosus. (1988) (26)
Primary Biliary Cirrhosis Specific Antinuclear Antibodies in Patients from Spain (2004) (26)
Serum autoantibodies: A road map for the clinical hepatologist (2008) (26)
Interferon‐free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis (2018) (26)
Juvenile autoimmune hepatitis: A comprehensive review. (2018) (26)
Circulating immune complexes in patients with fulminant hepatic failure. (1981) (26)
Cell‐mediated Immunity and Symptomatic Diabetic Autonomic Neuropathy (1988) (26)
Complement activation during bypass in acquired C1 esterase inhibitor deficiency. (1991) (26)
Aetiology of insulin-dependent diabetes. (1989) (26)
Serum interleukin-1 alpha and soluble interleukin-2 receptor concentrations in cystic fibrosis. (1993) (26)
Markers of immune cell activation and disease progression. Cell activation in HIV disease. (1995) (25)
Liver transplantation in children. (2007) (25)
Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway. (1988) (25)
Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection. (1992) (25)
Immunopathogenesis of hepatitis B virus recurrence after liver transplantation. (2000) (24)
Disease‐specific autoantibodies in patients with acute liver failure: The King's College London Experience (2008) (24)
Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers. (1986) (24)
Positive Markers in AMA-Negative PBC (2003) (24)
Methods for assessing complement activation in the clinical immunology laboratory. (1993) (24)
Persistent Activation of CD8+ T-cells Characterizes Prediabetic Twins (1996) (23)
Hepatitis C virus and autoimmunity. (2000) (23)
Soluble interleukin 2 receptors in autoimmune chronic active hepatitis. (1990) (23)
Autoimmmune hepatitis (2021) (23)
LKM antibody: getting in some target practice (2000) (22)
Autoimmune hepatitis in children. (2002) (22)
Frequency of mannose-binding protein deficiency in patients with systemic lupus erythematosus. (1995) (22)
Adaptive Immunity in Autoimmune Hepatitis (2010) (22)
Glutamic acid decarboxylase expression in islets and brain (1991) (22)
Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens. (1987) (21)
The impact of autoimmunity on hepatocytes. (2007) (21)
Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome. (2020) (21)
Different immunogenetic background in autoimmune hepatitis type 1, type 2 and autoimmune sclerosing cholangitis (2002) (21)
T suppressor cell function and number in children with liver disease. (1985) (21)
Autoimmune Hepatitis and PSC Connection. (2008) (21)
Elevation of activated gamma delta T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease. (1992) (21)
Activation of the alternative complement pathway: clinical application of a new technique to measure fragment Ba. (1987) (20)
[660] ANTIBODY RESPONSES SPECIFIC FOR SOLUBLE LIVER ANTIGEN CO-OCCUR WITH RO-52 AUTOANTIBODIES IN PATIENTS WITH AUTOIMMUNE HEPATITIS (2007) (20)
Borrelia Burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis. (2006) (20)
Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease. (1994) (20)
T cell clones generated from patients with type 1 diabetes using interleukin-2 proliferate to human islet antigens. (1994) (20)
Increased Expression of T-Cell Markers of Immunological Memory Associated with Protection from Type I Diabetes: A study of Identical Twins (1994) (19)
Regulatory T cells in autoimmune hepatitis: Un updated overview. (2021) (19)
Immunosuppressive drugs affect interferon (IFN)‐γ and programmed cell death 1 (PD‐1) kinetics in patients with newly diagnosed autoimmune hepatitis (2017) (19)
Complement activation in neonatal infection. (1992) (19)
Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease. (2011) (19)
Autoimmune sclerosing cholangitis: Evidence and open questions. (2018) (19)
Neonatal Liver Disease Associated with Placental Transfer of Anti-mitochondrial Antibodies (2002) (18)
Autoimmune hepatitis (2009) (18)
Antibodies to soluble liver antigen and α-enolase in patients with autoimmune hepatitis (2004) (18)
Abnormalities of CD45 isoform expression in HIV infection. (1996) (18)
Effect of Initiation of Insulin Therapy on T‐lymphocyte Activation in Type 1 Diabetes (1990) (18)
Lymphocyte cytotoxicity to halothane altered hepatocytes in patients with severe hepatic necrosis following halothane anaesthesia. (1980) (18)
NOSA in HCV infection: markers or makers of disease? (1999) (18)
Carcinoid heart disease from ovarian primary presenting with acute pericarditis and biventricular failure (1998) (17)
Identification of T cell epitopes on soluble liver antigen in Chinese patients with auto‐immune hepatitis (2011) (17)
Autoantibody and Human Leukocyte Antigen Profiles in Children With Autoimmune Liver Disease and Their First-Degree Relatives (2014) (17)
Specificity of anti‐sp100 antibody for primary biliary cirrhosis (2004) (17)
Biliary atresia (2009) (17)
Co-expression of CD45RA (naive) and CD45RO (memory) T-cell markers (1994) (16)
Autoimmune liver disease (2014) (16)
In vitro study of IgG production and concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection. (1986) (16)
Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse. (1993) (16)
Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation (2016) (15)
Immunohistochemical phenotyping of the inflammatory infiltrate in de novo autoimmune hepatitis after liver transplantation in children (2012) (15)
Influence of C4 null alleles on C4 activation in systemic lupus erythematosus. (1991) (15)
Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in Type 1 (insulin-dependent) diabetes mellitus (1993) (15)
Pancreatic malignant melanoma with occult primary lesion. A case report. (1992) (15)
Autoimmune hepatitis. (1996) (15)
Cytokine levels and profiles in children related to sickle cell disease and asthma status. (2012) (15)
Significance of extractable nuclear antigens in childhood autoimmune liver disease (1995) (15)
Cytochrome P450 1A2 is a target antigen in hepatitic graft-versus-host disease (2006) (14)
Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6 (1993) (14)
A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1. (1998) (14)
Human Leukocyte Antigen Profile Predicts Severity of Autoimmune Liver Disease in Children of European Ancestry (2021) (14)
[Myocardial scintigraphy by the gated SPECT method in coronary disease patients with postischemic stunning]. (1999) (14)
PLASMA EXCHANGE IN SLE (1980) (14)
Autoimmune hepatitis. (2009) (14)
Development of techniques for obtaining monodispersed human islet cells. (1994) (14)
Alcohol Dehydrogenase: An Autoantibody Target in Patients with Alcoholic Liver Disease (2005) (14)
Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus (1997) (14)
Complement activation in uveitis. (1986) (13)
Viruses and autoantibodies in biliary atresia. (2010) (13)
Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines. (2020) (13)
Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity. (1990) (13)
Anti-TNF&agr; Treatment in Children and Adolescents With Combined Inflammatory Bowel Disease and Autoimmune Liver Disease (2018) (12)
Yeast Opsonisation and Complement in Children with Liver Disease. Analysis of 69 Cases (1983) (12)
Sarcoidosis associated with combined immunodeficiency. (1980) (12)
Alpha 1-antitrypsin deficiency, complement activation, and chronic liver disease. (1991) (12)
FK506 in liver transplantation for chronic hepatitis B: In vitro studies on lymphocyte activation and virus replication (1995) (12)
T lyphocyte activation is associated with viral replication in chronic hepatitis B virus infection of childhood (1991) (11)
“Neonatal hemochromatosis”: A re‐vision (2010) (11)
The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers. (1986) (11)
British Association for the Study of the Liver (1991) (11)
Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. (2004) (11)
Autoimmune hepatitis: diagnostic and management challenges (2004) (11)
Aberrant hepatic trafficking of gut‐derived T cells is not specific to primary sclerosing cholangitis (2021) (11)
Analysis of peripheral blood mononuclear cells in rodents by three-colour flow cytometry using a small-volume lysed whole blood technique. (1993) (11)
The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator? (2018) (11)
Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays. (2002) (11)
Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-Ag7, which is also protective against the development of autoimmune diabetes (1999) (11)
Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents. (2019) (11)
P0295 VIRUS-SELF CROSSREACTIVITY INDUCING DE NOVO AUTOIMMUNE HEPATITIS EIGHT-YEARS AFTER LIVER TRANSPLANTATION (2004) (10)
Effect of ethnicity on the clinical presentation and outcome of autoimmune hepatitis (2012) (10)
Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda (2001) (10)
Autoimmune hepatitis. (2004) (10)
The effect of fish-oil on the remission of Type 1 (insulin-dependent) diabetes in newly diagnosed patients (1989) (10)
Therapeutic aspects of autoimmune liver disease in children (2005) (10)
Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with Type 1 (insulin-dependent) diabetes and their first degree relatives (1994) (10)
Liver-kidney microsomal antibody-positive autoimmune hepatitis in the United States (2001) (10)
CD5+ B-Cells at the Onset of Type I Diabetes and in the Prediabetic Period (1994) (10)
Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus. (1994) (9)
JOINT SYMPTOMS, IMMUNE COMPLEXES, AND RUBELLA (1980) (9)
Reproducibility and persistence of neural and adrenal autoantibodies in diabetic autonomic neuropathy (1997) (9)
Occurrence of circulating immune complexes in beta-thalassaemia major. (1978) (9)
LKM1-Positive Type 2 Autoimmune Hepatitis Following Allogenic Hematopoietic Stem-Cell Transplantation (2008) (9)
CLASSICAL COMPLEMENT PATHWAY IN HIV INFECTION (1989) (9)
Cutting Edge Issues in Autoimmune Hepatitis (2012) (9)
Immunological studies on type 1 diabetes in identical twins. (1993) (9)
Cytochrome P4502D6: understanding an autoantigen (1997) (9)
PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes (2022) (9)
Cross-reactivity to lactobacillus delbrueckii/human pyruvate dehydrogenase complex-E2 characterizes primary biliary cirrhosis. (2000) (9)
ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed. (2020) (9)
Autoimmune Liver Disease: News and Perspectives (2011) (8)
The role of viral-specific immune responses on the outcome of chronic hepatitis B (HBV) infection in children: new insights into immunopathology. (2007) (8)
Atovaquone/proguanil‐induced autoimmune‐like hepatitis (2017) (8)
Corrigendum to “Regulatory T-cells in autoimmune diseases: challenges, controversies and – yet – unanswered questions” [Autoimmun Rev 14/2 (2015) p.105–116] (2015) (8)
FK506 in liver transplantation for chronic hepatitis B: in vitro studies on lymphocyte activation and virus replication. (1996) (8)
Autoimmune disease: etiology, therapy and regeneration. (1994) (8)
Real-world management of juvenile autoimmune liver disease (2018) (8)
Anti-SLA antibody is a marker of severity of liver damage in patients with autoimmune liver disease (2001) (8)
Peripheral blood and intrahepatic subsets of T lymphocyte activation and function in liver allograft rejection and drug-induced tolerance in rats. (1996) (8)
Steroid-responsive autoimmune sclerosing cholangitis with liver granulocytic epithelial lesions. (2013) (8)
Prevalence of antibodies to hepatitis C and herpes simplex virus type 1 is not increased in children with liver kidney microsomal type 1 autoimmune hepatitis. (1996) (8)
Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice (2021) (8)
Complement Activation And C1q Binding Activity In Haemodialysis (1981) (7)
Activation of the classical complement pathway in spontaneous bacterial peritonitis. (1992) (7)
Real world management of juvenile autoimmune liver disease (2017) (7)
γδ† T CLONES FROM LIVER BIOPSIES OF CHILDREN WITH AUTOIMMUNE CHRONIC ACTIVE HEPATITIS (aCAH) AND PRIMARY SCLEROSING CHOLANGITIS (aPSC) ARE CYTOTOXIC TO HUMAN LIVER TARGET CELLS (1991) (7)
Hepatitis B virus infection in thalassaemia major treated in London and Athens. (1984) (7)
Paediatric Liver Disease (1987) (7)
Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases (2022) (7)
Evidence of impaired antigen non-specific but normal antigen specific suppressor cell function in children with autoimmune chronic active hepatitis. (1987) (6)
Autoimmune hepatitis: Diagnostic criteria and serological testing (2014) (6)
Double stranded DNA binding in autoimmune chronic active hepatitis and primary sclerosing cholangitis starting in childhood. (1989) (6)
The human leukocyte antigens (2009) (6)
Chapter 61 – Hepatitis (2014) (6)
1107 PHOSHORYLATION OF P38 MAPK IS DETECTABLE IN NKT CELLS OF PATIENTS WITH AUTOIMMUNE HEPATITIS IN WHOM IT MIRRORS DISEASE ACTIVITY (2010) (6)
Review: Complement and Lupus: Old Concepts and New Directions (1992) (6)
Expression of glutamic acid decarboxylase in nervous tissue structures targeted by autoantibodies in patients with diabetic autonomic neuropathy (1997) (6)
Acute alcoholic hepatitis and cellular Th1 immune responses to alcohol dehydrogenase (2015) (6)
Viral hepatitis: virus/host interaction (2004) (6)
Detection of brain-reactive autoantibodies in the sera of patients with systemic lupus erythematosus and cerebral involvement. (1995) (6)
Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays (2002) (6)
GLUTATHIONINE S-TRANSFERASE THETA 1 (GSTT1) MISMATCH DOES NOT ACCOUNT FOR POST LIVER TRANSPLANT DE NOVO AUTOIMMUNE HEPATITIS (2009) (6)
422 Possible predictive and diagnositic role of anti-SLA antibodies in autoimmune hepatitis after liver transplantation (2003) (6)
DYSFUNCTIONAL CD39 POS REGULATORY T CELLS AND ABERRANT CONTROL OF T HELPER TYPE 17 CELLS IN AUTOIMMUNE HEPATITIS REGULATORY CELLS IN AUTOIMMUNE HEPATITIS (2016) (6)
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination (2022) (6)
Hepatitis B virus: something old, something new. (2007) (6)
Comprar Basic and Clinical Immunology, 2nd Edition | Diego Vergani | 9780443100826 | Churchill Livingstone (2009) (6)
Contemporary issues and future directions in autoimmune hepatitis (2016) (6)
NEW VIRAL TRIGGERS OF AUTOREACTIVITY TO CYTOCHROME P4502D6, THE TARGET OF LIVER KIDNEY MICROSOMAL AUTOANTIBODY (1999) (5)
Events leading to insulin-dependent diabetes. (1989) (5)
PWE-281 Different effector T cell responses may account for different patterns of liver injury in childhood autoimmune liver disease (2012) (5)
[Detection and assessment of myocardial stunning with perfusion tomographic scintigraphy using gated SPECT]. (2000) (5)
HLA, gut microbiome and hepatic autoimmunity (2022) (5)
Treatment of hepatitis B virus in children: why, whom, how? (2006) (5)
Mouse model of primary biliary cholangitis with a striking female predominance: A new powerful research tool (2016) (5)
COMPLEMENT ACTIVATION IN PROGRESSIVE SYSTEMIC SCLEROSIS (1987) (5)
Antireticulin antibody in systemic sclerosis. (1990) (5)
Expression of intrahepatic hepatitis D viral antigen in chronic hepatitis D virus infection. (1991) (5)
[25] IDENTIFICATION OF HLA-DR3 RESTRICTED CD4 T-CELL EPITOPES ON SOLUBLE LIVER ANTIGEN IN AUTOIMMUNE HEPATITIS TYPE 1 (2007) (4)
Autoimmune hepatitis in childhood (2014) (4)
Autoimmune hepatitis and sclerosing cholangitis. (2004) (4)
Autoimmune liver disease in children. (2003) (4)
Detection of anti‐liver cell membrane antibody using a human hepatocellular carcinoma cell line (1989) (4)
Asian Pacific Association for Study of the Liver (APASL) (2003) (4)
96 autoimmune hepatitis after liver transplantation in children: a single centre experience (2003) (4)
γδ+ T clones from liver biopsies of children with autoimmune chronic active hepatitis and primary sclerosing cholancitis are cytotoxic to human liver target cells (1991) (4)
Radionuclide assessment of left ventricular function in patients with mycardial infarction and diabetes mellitus (1992) (4)
1300 REDUCED GALECTIN-9 EXPRESSION IS ASSOCIATED WITH DEFECTIVE T-REG CONTROL OF EFFECTOR CELLS IN PATIENTS WITH AUTOIMMUNE HEPATITIS (2011) (4)
Immunoregulation of immunoglobulin production in normal infants and children. (1985) (4)
Liver Disease Microsomal Autoantibody Type 1-Positive Virus / Self Cross-Reactivity in Liver Kidney Immunodominant Epitope and Target of : A New 212 − 193 Cytochrome P 4502 (2003) (4)
Low serum haemolytic function of the fourth complement component (C4) in insulin dependent diabetes. (1988) (4)
Cross-reactivity between mycobacterium gordonae and PDC-E2, the major target of anti-mitochondrial antibody, is present in Spanish but not British patients with PBC (2001) (4)
Hepatitis virus induced autoimmunity. (1998) (3)
INTERLEUKIN-1 (IL-1), SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL2R), TUMOUR NECROSIS FACTOR (TNF) and INTERFERONγ (IFNγ) IN CHILDREN WITH CHRONIC LIVER DISEASE (CLD) (1991) (3)
The Riddle of Juvenile Sclerosing Cholangitis (2017) (3)
Peginterferon Alfa-2a (40KD) Plus Lamivudine or Entecavir in Children With Immune-Tolerant Chronic Hepatitis B (2021) (3)
Generation of liver/kidney microsomal-1 antibody in HCV infection: The role of molecular mimicry (2000) (3)
Antibodies to human albumin epitopes in Type 1 (insulin-dependent) diabetes mellitus (1988) (3)
A Heterozygous ABCB4, RUNDC3B, and ABCB1 Deletion Associated With Severe Cholestatic Liver Disease in Adulthood (2019) (3)
Approach to a child with chronic liver disease (2004) (3)
Autoimmune hepatitis. (1996) (3)
Anti-lymphocytic antibodies in autoimmune chronic active hepatitis starting in childhood. (1989) (3)
Reply: To PMID 23787765. (2015) (3)
676 FINE SPECIFICITY OF ANTI-NUP62 T-HELPER 1 CELL (TH1) IMMUNE RESPONSE IN PRIMARY BILIARY CIRRHOSIS (2009) (3)
Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission. (1989) (3)
Cellular epitope mapping of cytochrome P4502D6 in patients with autoimmune hepatitis (2001) (3)
P15 Multiple defects of the immunoregulatory system contribute to the development of autoimmune hepatitis (2011) (3)
Autoantibodies to soluble liver antigen/UGA suppressor tRNA-associated antigenic protein are specific to autoimmune liver disease. (2000) (3)
539 Antibodies to soluble liver antigen in patients with autoimmune hepatitis: is alpha-enolase their target? (2004) (3)
Hepatic schistosomiasis and chronic active hepatitis. (1989) (3)
Circulating basement membrane zone antibodies in eczema (1984) (2)
Double reactivity to Ecoli/pyruvate dehydrogenase complex-E2characterises primary biliary cirrhosis (2000) (2)
AUTOIMMUNE LIVER DISEASE/SYSTEMIC LUPUS ERYTHEMATOSUS OVERLAP SYNDROME IN CHILDREN: PH2-10 (2005) (2)
A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome (2019) (2)
C4 function in children with autoimmune chronic active hepatitis (1989) (2)
Detection of hepatitis B virus pre-S1 and pre-S2 determinants in paraffin wax embedded liver tissue: importance of reagents used. (1991) (2)
Admission levels and early changes in serum IL-10 are associated with poor outcome in acute liver failure and acute-on-chronic liver failure (2007) (2)
Overlap syndromes from pediatrics to adulthood (2004) (2)
B-CELL EPITOPE MAPPING OF ANTI-RO-52 RESPONSES IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS (2010) (2)
A reasoned approach to the treatment of autoimmune hepatitis. (2021) (2)
Reassessement of the histological features of autoimmune hepatitis (2022) (2)
Immunology and the Liver (1992) (2)
DIFFERING IMMUNE MECHANISMS TRIGGERING AUTOIMMUNITY IN PRIMARY SCLEROSING CEOLANGITIS (PSC) AND AUTOIMMUNE CHRONIC ACTIVE HEPATITIS (aCAH) OF CHILDHOOD (1986) (2)
Primary Biliary Cirrhosis-Specific Antimitochondrial Antibodies in Neonatal Haemochromatosis (2013) (2)
Immunodominant HLA-A2 restricted CD8 T cell epitope in autoimmune hepatitis type 2. (2004) (2)
Autoimmune hepatitis. (2001) (2)
O0096 A NOVEL APPROACH TO THE TREATMENT OF CHRONIC HEPATITIS B IN PERINATALLY INFECTED ???TOLERANT??? CHILDREN (2004) (2)
Autoimmune Hepatitis and Sclerosing Cholangitis (2004) (2)
IMMUNE RESPONSES IN PATIENTS WITH OBSTRUCTIVE JAUNDICE OF INFANCY (1983) (2)
IDENTIFICATION OF NEW EPITOPES ON CYTOCHROME P4502D6 IN AUTOIMMUNE HEPATITIS AND CHRONIC HEPATITIS C VIRUS INFECTION (1999) (2)
FACTORS ASSOCIATED WITH RECURRENCE OF AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION AND EFFECTS ON GRAFT AND PATIENT SURVIVAL (2019) (2)
17 Functional impairment of CD25+CD4+ regulatory T cells characterizes autoimmune hepatitis type 2 (2003) (2)
HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy (2015) (2)
THU-037-Soluble MAdCAM-1 as a novel marker of hepatic endothelial dysfunction in acutely decompensated cirrhosis (2019) (2)
Virus/self double reactivity characterises the humoral immune responsein autoimmune hepatitis-2 (2000) (2)
Should Giant Cell Hepatitis With Autoimmune Haemolythic Anaemia Be Considered a Paediatric Autoimmune Liver Disease? (2018) (2)
626 In vitro immunosuppressive effect of vitamin D3 in primary biliary cirrhosis (2006) (2)
Towards the serological diagnosis of primary biliary cirrhosis (2015) (2)
Non-organ specific autoantibodies in HCV infection: do they matter (2005) (2)
Autoantibodies and Understanding of Autoimmune Liver Diseases (2020) (1)
861 A COMPLEX IMMUNOREGULATORY DEFICIENCY CHARACTERISES TYPE 1 AUTOIMMUNE HEPATITIS (2008) (1)
Narrowing of anti-cytochrome P4502D6 cellular immune responses in succesfully treated patients with autoimmune hepatitis type 2 (2003) (1)
Liver pathology associated with mitochondrial autoantibody in newborns is ofmaternal origin (2001) (1)
OP05 Medium term outcome of de novo autoimmune hepatitis after liver transplantation in children; a single centre experience (2010) (1)
Radionuclide assessment of cardiac function in diabetic patients after myocardial infarction. (1988) (1)
CD4 expression on liver sinusoidal cells: Enhancement in liver transplant rejection (1991) (1)
26 OUTCOME OF AUTOIMMUNE HEPATITIS (AIH) IN CHILDHOOD: PROGNOSTIC VALUE OF SERUM BILIRUBIN (1995) (1)
Should Giant Cell Hepatitis With Autoimmune Hemolythic Anemia Be Considered A Pediatric Autoimmune Liver Disease? (2018) (1)
Levels of soluble fas ligand, hepatocyte growth factor and proinflammatory cytokines in children with fulminant hepatic failure (1998) (1)
1301 INHIBITION OF TH17-CELL DEVELOPMENT ENHANCES THE SUPPRESSIVE FUNCTION OF NEWLY GENERATED T-REGS IN PATIENTS WITH AUTOIMMUNE HEPATITIS (2011) (1)
Hepatic Diseases - Sclerosing Cholangitis (2005) (1)
Treg conditioning endows activated Teff with suppressor function in juvenile autoimmune liver disease (2017) (1)
P58 Genetic, virological and immunological pre-treatment predictors of therapy response to Peg-IFN/ribavirin in children with chronic hepatitis C (2011) (1)
Liver membrane-specific T cell clones in autoimmune chronic active hepatitis (aCAH) (1989) (1)
957 THE T-CELL EFFECTOR PHENOTYPE PROFILE IN AUTOIMMUNE SCLEROSING CHOLANGITIS DIFFERS FROM THAT OF AUTOIMMUNE HEPATITIS (2012) (1)
The role of T cells in autoimmune hepatitis (2000) (1)
Treatment with prednisolone suppresses interleukin 1 soluble interleukin 2 receptor and immunoglobulin g in cystic fibrosis patients (1992) (1)
TIM3 DOWN-REGULATION RENDERS CD4 EFFECTOR CELLS LESS SUSCEPTIBLE TO T-REG CONTROL IN PATIENTS WITH AUTOIMMUNE HEPATITIS (2010) (1)
P0294 HLA DR7 POSITIVE PATIENTS WITH TYPE 2 AUTOIMMUNE HEPATITIS ARE CHARACTERISED BY A PROLONGED CLINICAL COURSE (2004) (1)
Thyroid peroxidase is a molecular mimicry target of anti-hepatitis C virus humoral response (2000) (1)
HUMORAL IMMUNITY IN CHILDREN WITH CYSTIC FIBROSIS(CF) AND CHRONIC LIVER DISEASE (CLD) (1990) (1)
[452] CHRONIC HEPATITIS C IS CHARACTERISED BY AN (2007) (1)
RESPONSE TO PEGYLATED INTERFERON plus RIBAVIRIN IN CHILDREN WITH CHRONIC HEPATITIS C IS ASSOCIATED WITH MORE SEVERE HAEMATOLOGICAL TOXICITY AND FEWER NEUROPSYCHIATRIC SYMPTOMS (2010) (1)
958 PHENOTYPIC AND FUNCTIONAL SIGNATURE OF CD4POSCD25HIGHCD127LOW REGULATORY T-CELLS IN AUTOIMMUNE HEPATITIS (2012) (1)
Endocrine autoimmune disease (2009) (1)
P386 Th17 EFFECTOR CELLS MAY BE INVOLVED IN THE BILE DUCT DAMAGE CHARACTERISTIC OF AUTOIMMUNE SCLEROSING CHOLANGITIS (2014) (1)
Broad cellular immune response to CYP2D6 is restricted by HLA DR7 in patients with type 2 autoimmune hepatitis (2003) (1)
1104 DYSREGULATION OF GAL-9/TIM3 PATHWAY MIRRORS T-REG IMPAIRMENT IN AUTOIMMUNE HEPATITIS (2010) (1)
953 CYTOCHROME P450IID6-SPECIFIC T-REGS GENERATED FROM PATIENTS WITH AUTOIMMUNE HEPATITIS TYPE-2 ARE PHENOTYPICALLY STABLE UPON EXPANSION AND PRO-INFLAMMATORY CHALLENGE (2012) (1)
959 REDUCED EXPRESSION OF INHIBITORY MOLECULES CHARACTERISES CD4 AND CD8 EFFECTOR CELLS IN AUTOIMMUNE HEPATITIS (2012) (1)
Complement and lupus: old concepts and new directions. (1992) (1)
98 ELEVATED IL-6 LEVELS PRESAGE AND ACCOMPANY ANTI-HBe SEROCONVERSION DURING INTERFERON TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION (1996) (1)
DELTA INFECTION IN THE U.K. (1983) (1)
869 ANALYSIS OF SPECIFIC AUTOANTIBODY PROFILES IN PRIMARY BILIARY LIVER CIRRHOSIS (2008) (1)
554 HLA DR7 positive patients with type 2 autoimmune hepatitis are characterised by a prolonged clinical course (2004) (1)
652 Juvenile autoimmune sclerosing cholangitis is associated with possession of HLA DRB1*13 (2006) (1)
P81 Psychiatric side effects of antiviral therapy with pegylated interferon and ribavirin are associated with poor response in children with chronic hepatitis C (2010) (1)
Cutting edge issues in juvenile sclerosing cholangitis. (2021) (1)
Predictive value of viral load monitoring in chronic hepatitis B virus infection treated with interferon-α (1998) (1)
HIGH CIRCULATING LEVELS OF INTERLEUKIN-10 BUT NOT TGF-[beta] 1 CHARACTERISE'TOLERANT'LIVER ALLOGRAFT RECIPIENTS (1999) (1)
Review: Assessment ofcomplement activation inclinical immunology laboratories: timeforreappraisal? (1989) (1)
P05 B-cell epitope mapping of anti-ro-52 responses in patients with primary biliary cirrhosis (2010) (1)
Chlamydia infection as risk factor for pediatric biliary tract disease. (2008) (1)
435 LOW NK CELL NUMBER, LOW HCV-SPECIFIC IL-10 PRODUCTION AND HIGH CD56BRIGHT CELL NUMBER PREDICT RESPONSE TO PEGYLATED-INTERFERON/RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C IN CHILDREN (2010) (1)
59. EXPRESSION OF CLASS I & CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX)MHC) ANTIGENS ON HEPATOCYTES ISOLATED FROM CHILDREN WITH LIVER DISEASE (1987) (1)
[670] A NEW SUBSTRATE FACILITATES THE DETECTION OF AUTOIMMUNE HEPATITIS SPECIFIC ANTI-SMOOTH MUSCLE ANTIBODIES (2007) (1)
Innate immunity I: physical and humoral protection (2009) (1)
678 DIAGNOSTIC AND CLINICAL APPLICATION OF A NEW LINE IMMUNOASSAY THAT SIMULTANEOUSLY DETECTS THE MULTIPLE NUCLEAR DOT SPECIFIC ANTIGENS IN PRIMARY BILIARY CIRRHOSIS (2009) (1)
Autoimmune hepatitis. (2003) (1)
P395 TIM-3 MODULATES TH17 RESPONSIVENESS TO T-REG CONTROL IN AUTOIMMUNE HEPATITIS AND HEALTH (2014) (0)
ACTIVATION OF CYTOTOXIC-SUPPRESSOR HLA-DR POSITIVE T LYMPHOCYTES IN CHRONIC HEPATITIS B VIRUS (HBV) INFECTION IN CHILDHOOD (1986) (0)
673 The newly characterized CD4+CD25+ regulatory T cells are defective in autoimmune hepatitis (2003) (0)
57 SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI) IS A PIVOTAL MEDIATOR OF ANTI-INFLAMMATORY RESPONSES IN ACUTE LIVER FAILURE (2013) (0)
554 T REGULATORY LYMPHOCYTES (T-REGS) IMPAIR EFFICIENT CONTROL OF HBV REPLICATION BY CURBING HBV-SPECIFIC T HELPER TYPE 1 RESPONSES (2009) (0)
Primary Sclerosing Cholangitis (2020) (0)
P66 Low pre-treatment plasma HBsAg level and its decline during add-on interferon treatment predict response to combined lamivudine/interferon therapy in tolerant children with infancy-acquired chronic hepatitis B (2011) (0)
[399] IMPAIRMENT OF MEMORY/EFFECTOR CELLS MATURATION MAY ACCOUNT FOR LACK OF VIRUS IMMUNE CONTROL IN PAEDIATRIC PATIENTS WITH HBV INFECTION (2007) (0)
58 CYTOKINE PRODUCING CELLS IN THE LIVER TISSUE DURING REJECTION OR INFECTION AFTER LIVER TRANSPLANT (1994) (0)
INTERLEUKIN-10 IS PIVOTAL TO THE "DYSREGULATED" INFLAMMATORY RESPONSE OF ACUTE LIVER FAILURE (2008) (0)
CYP2D6 245-254 induces cytotoxic activity of CD8 T lymphocytes in autoimmune hepatitis type 2 (2005) (0)
to measure fragment Ba . application of a new technique complement pathway : clinical Activation of the alternative (2005) (0)
Human immunodeficiency virus and AIDS (2009) (0)
O.060 The outcome of combined antiviral therapy in tolerant children with chronic hepatitis B is associated with emergence of mutations within HBV core gene immunodominant epitopes (2006) (0)
61. ANTINUCLEAR ANTIBODIES (ANA) ARE IgG1 SUBCLASS RESTRICTED IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS (aCAH) BUT NOT IN PRIMARY SCLEROSING CHOLANGITIS (PSC) OF CHILDHOOD (1987) (0)
Immune-mediated skin disease (2009) (0)
Complement in Type 1 (insulin-dependent) diabetes (1987) (0)
P.107 Variant strains of HBV contribute to clinical outcome of combination therapy with lamivudine and interferon-alpha in tolerant children with chronic hepatitis B (2006) (0)
SHodges, ALobo-Yeo, PDonaldson, M STanner, D Vergani (2011) (0)
Correlation oftheactivation ofthefourth component ofcomplement (C4)withdisease activity insystemic lupuserythematosus (1988) (0)
Liver autoimmune disease (2002) (0)
537 Elevated levels of B-cell activating factor characterise autoimmune hepatitis (2004) (0)
Hypersensitivity reactions and clinical allergy (2009) (0)
Special issue: Liver autoimmune disease - Introduction (2002) (0)
LIVER , BILIARY AND PANCREAS Soluble interleukin 2 receptors in autoimmune chronic active hepatitis (2006) (0)
Anatomy and cells of the immune system (2009) (0)
“Autoimmune diseases in pediatric gastroenterology ". Falk Symposium 127 (2002) (0)
The roleof E . coli infection in the pathogenesis of primary biliary cirrhosis (2014) (0)
Definition of Cytochrome P450 1A2 as a Target Autoantigen in the Hepatitic Variant of Hepatic Chronic Graft-Versus-Host Disease. (2005) (0)
Liver, Pancreas and Biliary Tract Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection (2003) (0)
57. A NEW METHOD FOR DETECTING ANTI LIVER CELL MEMBRANE ANTIBODY USING A HUMAN HEPATOMA CELL LINE (1987) (0)
947 POSSESSION OF HLA DR3 PREDICTS GOOD RESPONSE TO IMMUNOSUPPRESSIVE TREATMENT IN CHILDREN WITH AUTOIMMUNE LIVER DISEASE (2013) (0)
553 HIGH EXPRESSION OF PD-1 ON CD4+ LYMPHOCYTES MAY INTERFERE WITH VIRUS CONTROL IN HEPATITIS B CHRONICALLY INFECTED CHILDREN BY CURBING ANTIGEN-SPECIFIC T HELPER 1 RESPONSES (2009) (0)
Immune Changes before the Onset of Insulin-Dependent Diabetes (1988) (0)
Definition of immunodominant B cell epitopes on soluble liver antigen (SLA) and their implication for molecular mimicry. (2001) (0)
Immunology of chronic liver diseases (WS-084) Chairpersons: Tetsuo Takehara, Norihiko Watanabe (2010) (0)
CYP2D6-SPECIFIC CD4+CD25+REGULATORY T-CELLS INHIBIT TH1 AND TH17, BUT PROMOTE TH2 CYTOKINE SECRETION IN PATIENTS WITH AUTOIMMUNE HEPATITIS TYPE 2 (2008) (0)
32 CIRCULATING MONOCYTE ENDOTOXIN TOLERANCE IN ACUTE LIVER FAILURE: ROLE OF HEPATICALLY DERIVED IL-10 (2011) (0)
CHARACTERISATION OF THE PORTAL TRACT T LYMPHOCYTES DURING REJECTION OR INFECTION IN CHILDREN AFTER LIVER TRANSPLANT (1994) (0)
IN VITRO DETECTION OF B LYMPROCYTES PRODUCING SPECIFIC AUTOANTIBODY IN AUTOIMMUNE CHRONIC LIVER DISEASE (1991) (0)
A NEW AUTOANTIGEN IN AUTOIMMUNE LIVER DISEASE: ARGININOSUCCINATE LYASE (1997) (0)
Evaluation of post ischemic stunned patients by 99m-Tc Tetrofosmin Gated SPECT (1999) (0)
Mechanisms of Autoimmunity (1994) (0)
PTU-010 Role for GPR15 rather than beta 7 integrins in the pathogenesis of autoimmune liver disease (2019) (0)
[Right ventricular infarct and atrioventricular blocks]. (1987) (0)
P57 The IL28B gene SNP rs12979860 CC haplotype, predictor of response to treatment in chronic HCV infection, is associated to high numbers of CD56bright NK cells, low numbers of CD3-CD56-CD16+ NK cells and low HCV-specific IL-10 production (2011) (0)
Cellular immune responses I: dendritic cells, macrophages and B lymphocytes (2009) (0)
CD4+CD25+ T-REGS maintain the ability to suppress CD4 T-cell function in patients with autoimmune liver disease (2004) (0)
peritonitis . pathway in spontaneous bacterial Activation of the classical complement (2006) (0)
555 EFFICIENT CONTROL OF HEPATITIS B VIRUS REPLICATION IS LINKED WITH STRONG HBV-SPECIFIC IMMUNE REACTIVITY AND LOW NUMBER OF MUTATIONS IN HBV CORE GENE IMMUNODOMINANT EPITOPES (2008) (0)
62. LOW C4 HAEMOLYTIC FUNCTION IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS (aCAH)OF CHILDHOOD (1987) (0)
A key to conformational epitope on the C-terminal end of cytochrome P4502D6 recognised by liver kidney microsomal antibodies is located on the surface of the molecule (2002) (0)
Autoimmune hepatitis and primary scleorsing cholangitis (2002) (0)
P0292 ANTIBODIES TO SOLUBLE LIVER ANTIGEN IN PATIENTS WITH AUTOIMMUNE HEPATITIS: IS ALPHA-ENOLASE THEIR TARGET? (2004) (0)
389 Virus control within families of children vertically infected by hepatitis B depends on both host immune response and virus ability to mutate (2006) (0)
Prevalence of antibodies to formiminotransferase cyclodeaminase (FTDC) - The target antigen of liver cytosol type 1 - In patients with autoimmune liver disease (2003) (0)
Comparison between TI-201 transmission-emission SPECT images, with and without attenuation correction in CAD patients [Confronto tra immagini SPECT trasmissive-emissive corrette per attenuazione e non corrette, ottenute con TI-201 in coronaropatici] (1999) (0)
Chronic Virus Infection Nuclear and Smooth Muscle Antibodies in Polymerase and the Antigenic Targets of Mimicry Between the Hepatitis B Virus DNA (1999) (0)
Anti conformational CYP2D6 antibody levels correlate with histologically assessed liver damage in patients with LKM1 positive chronic hepatitis C (1998) (0)
P36 Block of interferon γ and co-culture with smDCs enhance antigen-specific T-reg suppression ability in autoimmune hepatitis type 2 (2010) (0)
PMO-155 Low pre-treatment HBsAG plasma levels, on therapy HBsAG levels decline and IP-10 concentrations increase predict response to treatment in tolerant children with chronic hepatitis B (2012) (0)
When and How to Treat the Pediatric Patient (2012) (0)
Effect of combined lamivudine and interferon alpha treatment on the T-cell response to HBV core peptides in paediatric patients infected with chronic hepatitis B virus. (2001) (0)
Complement activation inneonatal infection (2011) (0)
A new ELISA measuring antibodies to islet cell membranes: levels are increased in type 1 diabetes. (1992) (0)
Definition of the antigenic regions of cytochrome P4502D6 recognized by liver kidney microsomal antibody in autoimmune hepatitis and HCV infection (1998) (0)
PROGNOSTIC VALUE OF PROINFLAMMATORY CYTOKINES IN CHILDREN WITH FULMINANT HEPATIC FAILURE. (1997) (0)
1145 HIGH NUMBERS OF CD56BRIGHT, CD56DIM/NKG2D+ AND LOW NUMBERS OF CD3 CD56 CD16+ NK-CELLS ARE ASSOCIATED WITH LOW HCV-SPECIFIC IL-10 PRODUCTION AND PREDICT TREATMENT-RESPONSE IN CHRONIC HEPATITIS C (2011) (0)
T-regs impairment in autoimmune hepatitis is associated with low levels of FOXP3 (2005) (0)
Prevalence and specificity of antibodies to formiminotransferase cyclodeaminase in patients with autoimmune liver disease (2003) (0)
[A comparison between attenuation-corrected and -uncorrected transmission-emission SPECT images obtained with Tl-201 in CAD patients]. (1999) (0)
Immunohistochemical perforin staining allows differentiation between hepatitis C recurrence and rejection post-liver transplant (2006) (0)
Reflection ofdisease activity inrheumatoid arthritis byindices ofactivation oftheclassical complement pathway (1989) (0)
Reply to : ‘ ‘ Regulatory T cells in autoimmune hepatitis ’ ’ JOURNAL OF HEPATOLOGY (2012) (0)
Lamivudine and alpha interferon treatment for low responders HBV infected children: A preliminary report. (2001) (0)
HEPATIC MACROPHAGE POPULATION IN ACETAMINOPHEN-INDUCED LIVER FAILURE: WHERE DO THEY COME FROM AND WHAT IS THEIR ROLE? (2010) (0)
PWE-114 Modulation of non-canonical nfkb pathways may underlie the anti-inflammatory, resolution-like activation of circulating cd14hi monocytes in hyper-acute liver failure (2015) (0)
[Immunological aspects of halothane hepatoxicity]. (1987) (0)
58. DIFFERING EXPRESSION OF ANTIBODIES TO DOUBLE STRANDED DNA IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS (aCAH) & PRIMARY SCLEROSING CHOLANGITIS (PSC) (1987) (0)
DIAGNOSTIC AND CLINICAL SIGNIFICANCE OF ANTI-RO52 ANTIBODIES IN 609 CASES WITH PRIMARY BILIARY CIRRHOSIS FROM UK, SPAIN AND GREECE (2009) (0)
Cytokine profile defines different responses to interferon-alpha treatment in chronic hepatitis C virus infection (2006) (0)
64 ANTIGEN-SPECIFIC REGULATORY T-CELLS IN AUTOIMMUNE HEPATITIS TYPE 2: CYTOKINE PROFILE AND EFFECT OF SEMI-MATURE DENDRITIC CELLS ON SUPPRESSOR FUNCTION (2010) (0)
Immune-based therapies (2009) (0)
Acute hepatitis after COVID-19 vaccine: case series by the International autoimmune hepatitis group (IAIHG) and the european reference network on hepatological diseases (ERN RARE-LIVER) (2022) (0)
Autoimmune serology in liver disease: methodology and interpretation (2004) (0)
The immune response to microbes: an overview (2009) (0)
Epitope mapping of alcohol dehydrogenase in autoimmune hepatitis and alcoholic liver disease (2000) (0)
540 Extensive homology between the major immunodominant mitochondrial antigen of primary biliary cirrhosis and helicobacter pylori does not lead to immunological crossreactivity (2004) (0)
Immunology and Liver Disease / Liver and Metabolic Syndrome: Immunology and Liver Disease Falk Workshop 2009, Hannover, October 2009 / Liver and Metabolic Syndrome Falk Symposium 171, Hannover, October 2009 (2010) (0)
P0342 AUTOIMMUNE HEPATITIS TYPE 3 IN CHILDREN (2004) (0)
Reactivity to soluble liver antigen is associated with HLA A1-B8-DR3 in patients with autoimmune liver disease (2002) (0)
798 The immunoparalysis of acute liver failure (ALF) is reversed by orthotopic liver transplantation (OLT) (2003) (0)
P67 Combined innate and adaptive immune responses are needed to control hepatitis B virus replication in children with infancy-acquired infection (2010) (0)
486 Mutations in HBV core18–27 immunodominant epitope evade viral control of cytotoxic t lymphocytes during combined antiviral treatment in tolerant children with chronic hepatitis B (2006) (0)
THE ROLE OF HERPES SIMPLEX VIRUS TYPE 1 IN THE INDUCTION OF PROMYEOLOCYTIC LEUKAEMIA SPECIFIC RESPONSES IN PRIMARY BILIARY CIRRHOSIS (2009) (0)
HIGH PREVALENCE OF ANTIBODIES TO SOLUBLE LIVER ANTIGEN (SLA) IN CHILDREN WITH ACUTE LIVER FAILURE: PH2-21 (2005) (0)
P0337 INNATE AND ADAPTIVE IMMUNITY IN FULMINANT HEPATITIS B (2004) (0)
Tolerance and mechanisms of autoimmunity (2009) (0)
PTU-016a Functional defects in circulating monocytes may contribute to susceptibility to infection in alcoholic hepatitis (2012) (0)
[672] DETECTION OF ANTI-NUCLEAR PORE COMPLEX ANTIBODIES IN PRIMARY BlLlARY CIRRHOSIS: A COMPARISON BETWEEN WESTERN BLOT ANALYSIS AND INDIRECT IMMUNOFLUORESCENCE (2007) (0)
644 CD4 and CD8 T cell apoptosis is reduced in autoimmune hepatitis and not influenced by CD4+CD25+ regulatory T-cells (2006) (0)
Adaptive Immunity and the Clinical Definition of Autoantibodies (2020) (0)
Shape-selective alkylation of biphenyl over zeolite catalysts (1995) (0)
205 HIGH FREQUENCY OF ANTI-CARDIOLIPIN AND ANTIBETA2 - GLYCOPROTEIN-I POSITIVITY IN PAEDIATRIC LIVER TRANSPLANT RECIPIENTS DEVELOPING VASCULAR COMPLICATIONS (2008) (0)
434 HIGH FREQUENCY OF POLYFUNCTIONAL NATURAL KILLER CELLS WITH HIGH EXPRESSION OF NKG2D IS LINKED TO HBV-SPECIFIC T-HELPER TYPE 1 IMMUNE CONTROL (2010) (0)
P14 Phenotypic and functional profile of CD4posCD25high regulatory T cells in autoimmune hepatitis/systemic lupus erythematosus overlap syndrome (2011) (0)
Interleukin-1cx, soluble interleukin-2 receptor, andIgGconcentrations incystic fibrosis treated withprednisolone (1994) (0)
PMO-158 RS12979860 CC genotype is associated with baseline high numbers of CD56bright NK-cells, low numbers of CD3-CD56-CD16+ cells, low IL-10 HCV-specific production in CH-C therapy responders (2012) (0)
[Complement evaluation in the laboratory]. (1996) (0)
945 PHENOTYPIC CHARACTERISATION OF CD4 EFFECTOR IMMUNE RESPONSES IN CHILDHOOD AUTOIMMUNE LIVER DISEASE (2013) (0)
[Medcial complications in herion addicts]. (1977) (0)
909 LOWER MONOCYTE HLA-DR AND CD86 BUT MAINTAINED HLA-DQ. AND HIGHER CD80 EXPRESSION IN PARACETAMOL-INDUCED-ACUTE-LIVER-FAILURE: A PHENOTYPIC SWITCH TO INHIBITORY ANTIGEN PRESENTATION (2011) (0)
748 Evidence that an E. coli replication primase peptide, highly homologous to the major SP100 epitope, is a possible trigger of anti-SP100 reactivity in primary biliary cirrhosis (2003) (0)
Modulation of the Non-Canonical NFKB Pathways may Underlie Alternative Activation of Circulating CD14HI Monocytes in Hyper-Acute Liver Failure (2016) (0)
Role of molecular mimicry in viral and autoimmune Liver Disease (2002) (0)
[The complement system: a fascinating biological chain of events]. (1993) (0)
PMO-136 Defective inhibitory molecules expression may contribute to breakdown of tolerance characteristic of autoimmune liver disease (2012) (0)
[671] MONOCYTES FROM PATIENTS WITH AUTOIMMUNE HEPATITIS DISPLAY ENHANCED ABILITY TO MIGRATE WHICH IS NOT DOWN-REGULATED BY CD4+CD25+ REGULATORY T-CELLS (2007) (0)
Cell composition of interface hepatitis: A study on fixed liver sections (2003) (0)
Dynamics of HBV-specific CD4 and CD8 response during early phase of acute hepatitis B (2000) (0)
Chapter 6 – Autoimmune Hepatitis (2017) (0)
97 PREVALENCE OF ANTIBODIES TO HEPATITIS C AND HERPES SIMPLEX VIRUS TYPE 1 IS NOT INCREASED IN LKM- 1 POSITIVE AUTOIMMUNE HEPATITIS (1996) (0)
519 CELLULAR TH1 AND TH2 IMMUNE RESPONSES TO ALCOHOL DEHYDROGENASE WITHIN THE LIVER OF PATIENTS WITH ALCOHOL-RELATED CIRRHOSIS DESPITE ABSTINENCE (2013) (0)
P388 NK AND NKT CELLS EXPRESSING CD161 – A C-TYPE LECTIN CONFERRING REGULATORY PROPERTIES – ARE MARKEDLY REDUCED IN AUTOIMMUNE HEPATITIS (2014) (0)
Activation ofthealternative complement pathway: clinical application ofa new technique tomeasure fragment Ba (1987) (0)
643 Defective CD4+CD25+ T-regulatory cell ability to induce TGF-β secretion in autoimmune hepatitis is associated with reduced level of TGF-β gene expression (2006) (0)
Immunoglobulin G3 subclass anti-mitochondrial antibodies are associated with a more severe disease course in primary biliary cirrhosis (2006) (0)
OP22 A significant reduction in “pro-inflammatory” CD14lo/CD16hi monocytes in paracetamol-induced acute liver failure: association with outcome and CCR2 expression (2010) (0)
Autoreactive T cells: any evidence in autoimmune liver disease? (2005) (0)
Immune-mediated nephritis and vasculitis (2009) (0)
142 Prognostic value of actin-free GC-globulin in children with acute liver failure (2006) (0)
Immunological manifestations of haematological disease (2009) (0)
Chapter 13 Autoimmune Hepatitis (2008) (0)
P101 Regulatory T cells exhibit reduced phenotypic stability upon pro-inflammatory challenge in autoimmune hepatitis (2011) (0)
Reply: (2002) (0)
Prognostic value of hepatocyte growth factor in haemophagocytic lymphohistiocytosis (1998) (0)
systemic lupus erythematosus . Influence of C 4 null alleles on C 4 activation in (0)
T helper 1 cytokine dynamic profile during successful alpha interferon treatment of hepatitis B virus infection (2001) (0)
The endecamer CYP2d6317–327 accounts for differential reactivity of liver kidney microsomal antibody in autoimmune hepatitis type 2 and HCV infection (2000) (0)
T-CELL ANTIGEN RECEPTOR V GENE USAGE OF T-CELL CLONES DERIVED FROM LIVER BIOPSIES OF CHILDREN WITH AUTOIMMUNE LIVER DISEASE (1991) (0)
A broad and strong HBV core-specific T cell reactivity characterizes sustained viral control in children with chronic hepatitis B treated with combined lamivudine and interferon-alpha (2005) (0)
INFLAMMATORY CYTOKINES, IFN gamma, IL-17 AND IL-23, PRODUCING T CELLS FROM DONOR LIVERS CONTRIBUTE TO ACUTE REJECTION AFTER LIVER TRANSPLANTATION (2010) (0)
148 ANTI-LIVER CYTOSOLIC ANTIGEN TYPE 1 (LC1) ANTIBODIES IN CHILDHOOD AUTOIMMUNE LIVER DISEASE (1994) (0)
1105 CYP2D6-PULSED SEMI-MATURE DENDRITIC CELLS ENHANCE ANTIGEN-SPECIFIC SUPPRESSOR FUNCTION OF CD4POS CD25POS T-REGS IN PATIENTS WITH AUTOIMMUNE HEPATITIS TYPE 2 (2010) (0)
British Association for the Study of the Liver Meeting (2000) (0)
Effect offresh frozen plasma andgammaglobulin on humoral immunity inneonatal sepsis (1994) (0)
Shared amino acid sequences between glutamic acid decarboxylase 65 and 67 and alpha-2-macroglobulin. A focus for cross-reactive autoantibodies? (1995) (0)
134 REACTIVITY TO NATIVE ASIALOGLYCOPROTEIN RECEPTOR AND ITS SUBUNITS IN AUTOIMMUNE LIVER DISEASE (1996) (0)
P94 Rapamycin helps maintain the regulatory phenotype of cytochrome P450IID6-specific Treg expanded from patients with autoimmune hepatitis type 2 by reducing the number of IFNγ+ cells (2011) (0)
Hepatitis B surface antigen and myelin oligodendrocyte glycoprotein: A study of molecular mimicry. (2001) (0)
Single Dilation of Symptomatic Schatzki Ring With a Large Dilator Is Safe and Effective (2001) (0)
547 Effect of CD4+CD25+ regulatory T-cells on IFN-gamma production by CD8-cells in autoimmune hepatitis type 1 (2004) (0)
Liver transplantation in metabolic liver diseases (2004) (0)
DELTA HEPATITIS (1987) (0)
27 ANTI-HUMAN ALPHA-ENOLASE ANTIBODIES ARE HIGHLY PREVALENT IN AND SPECIFIC FOR BILIARY ATRESIA (2011) (0)
Autoimmune manifestations in viral hepatitis (2012) (0)
P04 A dose effect of the disease risk gene HLA DR3 contributes to numerical and functional impairment of CD4+CD25+ regulatory T cells in patients with autoimmune hepatitis (2011) (0)
100 ALCOHOL DEHYDROGENASE: A TARGET OF AUTOIMMUNE REACTION IN AUTOIMMUNE LIVER DISEASE (1995) (0)
PMO-156 Plasma HBsAG levels correlate with liver cccDNA in tolerant children with infancy acquired chronic hepatitis B infection (2012) (0)
554 EX-VIVO RECOMBINANT INTERLEUKIN-2 (IL-2) IMPROVES MATURATION AND FUNCTION OF HBVSPECIFIC EFFECTOR T CELLS IN PATIENTS WITH CHRONIC HEPATITIS B (2008) (0)
Hepatitis C virus infection: A molecular mimicry paradigm of viral triggered thyroid autoimmunity (2000) (0)
133 STRUCTURAL SIMILARITY AND HUMORAL CROSS-REACTIVITY IN TARGET ANTIGENS OF ORGAN SPECIFIC AUTOIMMUNE DISORDERS (1996) (0)
F1F0-ATPASE AS AN AUTOANTIGENIC TARGET IN PATIENTS WITH ANTI-MITOCHONDRIAL ANTIBODY NEGATIVE PRIMARY BILIARY CIRRHOSIS (2010) (0)
Ex-vivo helper profile of CYP2D6-specific T cells and its role in autoimmune hepatitis type 2. (2004) (0)
ELISA methods for the estimation of C3d. (1989) (0)
Increased serum levels of IL-10 and reduced monocyte HLA-DR expression reflect the severity of acetaminophen induced acute liver failure (2005) (0)
502 LOW PRE-TREATMENT HBSAG PLASMA LEVELS, DURING TREATMENT HBSAG LEVELS DECLINE AND IP-10 CONCENTRATIONS INCREASE PREDICT RESPONSE TO THERAPY IN TOLERANT CHILDREN WITH CHRONIC HEPATITIS B (2012) (0)
99 FUNCTIONAL DEFECTS IN CIRCULATING MONOCYTES MAY CONTRIBUTE TO INCREASED SUSCEPTIBILTY TO INFECTION IN ALCOHOLIC HEPATITIS (2012) (0)
Subject Index Vol. 33, Suppl. 2, 2015 (2015) (0)
Reply: (2010) (0)
Serial profiling of soluble mediators of inflammation in biliary atresia characterization of the fundamental inflammatory process (2005) (0)
98 RELEVANCE OF ORGAN AND NON- ORGAN SPECIFIC AUTOANTIBODY TITRES AND IgG LEVELS IN THE MONITORING OF CHILDHOOD AUTOIMMUNE LIVER DISEASE (1995) (0)
873 LOW PRE-TREATMENT NUMBERS OF CD4+/PD-1+ LYMPHOCYTES AND T REGULATORY LYMPHOCYTES PREDICT SUCCESSFUL RESPONSE TO PEGYLATED- INTERFERON/RIBAVIRIN THERAPY IN CHILDREN WITH CHRONIC HEPATITIS C (CH-C) (2009) (0)
Complement (2009) (0)
Detection ofhepatitis Bvirus pre-SI andpre-S2 determinants inparaffin wax embeddedliver tissue: Importance ofreagentsused (2011) (0)
Tracking the source of the restored HBV-specific CD8 cell response during lamivudine therapy (2001) (0)
Kinetics of the HBV-specific CTL response (1999) (0)
LONGITUDINAL COMPARISON OF ANTI-CYTOCHROME P4502D6 ANTIBODY AND LIVER KIDNEY MICROSOMAL ANTIBODY LEVELS WITH DISEASE ACTIVITY IN PATIENTS WITH AUTOIMMUNE HEPATITIS (1998) (0)
Autoantibodies to autonomic nervous tissues in diabetic neuropathy (1993) (0)
A SIGNIFICANT REDUCTION IN 'PRO-INFLAMMATORY' CD14LO/CD16HI MONOCYTES IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE: ASSOCIATION WITH OUTCOME AND CCR2 EXPRESSION (2010) (0)
PMO-114 Low CD39 expression marks severe regulatory t cell impairment in patients with autoimmune sclerosing cholangitis (2012) (0)
552 Primary biliary cirrhosis (PBC) specific antinuclear antibodies (ANA) have prognostic value and a distinct immunoglobulin isotype profile (2004) (0)
Longitudinal analysis of mutations within the HBV core gene in children with chronic hepatitis B treated with lamivudine/interferon-alpha combination therapy (2005) (0)
Reply (2015) (0)
Use of a molecularly based assay for the detection of antimitochondrial antibody M2 (2000) (0)
674 MONOCYTE OVER-ACTIVATION ESCAPES T-REG CONTROL IN AUTOIMMUNE HEPATITIS (2009) (0)
499 INTENSITY OF CELLULAR IMMUNE RESPONSES TO ALCOHOL DEHYDROGENASE IS ASSOCIATED WITH ALCOHOL CONSUMPTION IN PATIENTS WITH ALCOHOLIC LIVER DISEASE (2011) (0)
P315 PATIENTS WITH ACUTE ALCOHOLIC HEPATITIS PRESENT STRONG CELLULAR Th1 IMMUNE RESPONSES TO ALCOHOL DEHYDROGENASE (2014) (0)
Primary sclerosing cholangitis in pediatrics: what is different? (2004) (0)
645 Possession of HLA DRB1*13 is associated with a more severe course of juvenile autoimmune liver disease (2006) (0)
101 Sequential investigation of histocompatibility leucocyte antigen-DR positive (PBM-HLADR) monocytes in acetaminophen induced acute liver failure (AALF): Correlation with hepatocellular necrosis (2004) (0)
P95 Molecular mechanisms of monocyte reprogramming in acute liver failure: importance of hepatically derived anti-inflammatory mediators (2011) (0)
List of Contributors (2020) (0)
Expression of CD45 Isoforms in Disease: Is Memory Made of This? (1994) (0)
CYP2D6 specific T cell response in autoimmune hepatitis type 2: Analysis of the cytokine profile (2002) (0)
149 The significance of autoantibodies and immunoglobulins in acute liver failure (2006) (0)
92 THE HEPATIC INFLAMMATORY MICROENVIRONMENT INDUCES ENDOTOXIN TOLERANT MONOCYTES IN ACETAMINOPHEN-INDUCED LIVER FAILURE (2012) (0)
Cellular immune responses II: T lymphocytes, antigen presentation and natural killer cells (2009) (0)
Acquired immunity: antigen receptors (2009) (0)
871 GENERATION OF FUNCTIONAL CYP2D6-SPECIFIC CD4+CD25+ T-REGS IN PATIENTS WITH AUTOIMMUNE HEPATITIS TYPE 2 (2008) (0)
P0161 PP CD4+CD25+ T REGS MAINTAIN THE ABILITY TO SUPPRESS CD4 T CELL FUNCTION IN PATIENTS WITH AUTOIMMUNE LIVER DISEASE (2004) (0)
Characterisation of anti-nuclear reactivity in autoimmune hepatitis and sclerosing cholangitis (2001) (0)
ANTIRETICULIN ANTIBODIES IN SYSTEMIC SCLEROSIS. AUTHOR'S REPLY (1992) (0)
COMBINED INNATE AND ADAPTIVE IMMUNE RESPONSES ARE NEEDED TO CONTROL HBV REPLICATION IN CHILDREN WITH INFANCY-ACQUIRED INFECTION (2010) (0)
773 RS12979860 CC GENOTYPE IS ASSOCIATED WITH BASELINE HIGH NUMBERS OF CD56BRIGHT NK-CELLS, LOW NUMBERS OF CD3-CD56-CD16– CELLS, LOW IL-10 HCV-SPECIFIC PRODUCTION IN CH-C THERAPY RESPONDERS (2012) (0)
Autoantibodies to uroporphyrinogen decarboxylase in patients with porphyria cutanea tarda (1998) (0)
872 CHARACTERIZATION OF CD4 T-CELL IMMUNE RESPONSE TO NUCLEOPORIN P62 IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS (2008) (0)
555 HBeAg CLEARANCE AND EFFICIENT CONTROL OF HBV REPLICATION IS LINKED TO HIGH NUMBER OF NATURAL KILLER CELLS (2009) (0)
P28 Defective T-regulatory function in autoimmune hepatitis may partially derive from a pro-inflammatory skewing of Gal9+T-regs (2011) (0)
944 PHENOTYPIC AND FUNCTIONAL PLASTICITY OF CD4posCD25highCD127pos AND CD4posCD25highCD127neg T CELLS IN AUTOIMMUNE HEPATITIS (2013) (0)
HBV core gene mutations evade immune control (2005) (0)
ANTIBODIES TO THE HUMAN CYTOCHROME-P450 DB1 ARE NOT UNIVERSALLY ASSOCIATED WITH TYPE-II AUTOIMMUNE CHRONIC ACTIVE HEPATITIS (1991) (0)
T Cells in Health and Autoimmune Hepatitis Regulatory + CD25+ Functional Study of CD4 (2006) (0)
[666] INTRAHEPATIC T-HELPER AND REGULATORY T-CELLS IN AUTOIMMUNE HEPATITIS AND CHRONIC HCV INFECTION (2007) (0)
P387 REGULATORY T-CELL IMPAIRMENT IN AUTOIMMUNE LIVER DISEASE IS LINKED TO AN ABERRANTLY HIGH EXPRESSION OF CD127 (2014) (0)
MAdCAM-1 expression is absent in the hepatic tissue of paediatric autoimmune liver disease with associated inflammatory bowel disease (2017) (0)
Circulating cytomegalovirus DNA in liver graft rejection (2000) (0)
Innate immunity II: cellular mechanisms (2009) (0)
Predominance of T helper 1 virus specific immune response favours virus control in childhood hepatitis B virus infection (2007) (0)
60. IgG SUBCLASSES IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS (aCAH) OF CHILDHOOD (1987) (0)
34. EVIDENCE THAT HEPATITIS C VIRUS (HCV) INDUCES ANTI LIVER‐KIDNEY MICROSOMAL 1 (LXM1) PRIMARY AUTOIMMUNE RESPONSE (1993) (0)
Horizons in Medicine (2003) (0)
Autoimmune liver disease in Asian children (2015) (0)
Autoimmune hepatitis. (1996) (0)
Liver transplantation in children. (2007) (0)
PTU-015 Expanded CD14hi/CD16+ monocytes in acute liver injury (ALI): angels or demons? (2012) (0)
Chapter 6. ESPGHAN's Contributions to Paediatric Hepatology. (2018) (0)
P0291 Elevated Levels Of B-cell Activating Factor Characterise Autoimmune Hepatitis (2004) (0)
654 Impaired CD39 Expression and Persistence of Th17 Cell Effector Functions in Autoimmune Liver Disease (2015) (0)
642 Chlamydia pneumoniae liver gene expression and anti-chlamydial antibody response in patients with primary biliary cirrhosis (2006) (0)
DETECTION OF ANTI CONFORMATIONAL CYP2D6 ANTIBODIES IN PATIENTS WITH AUTOIMMUNE LIVER DISEASE AND HCV INFECTION USING A NOVEL RADIOLIGAND ASSAY (1997) (0)
Clinical application ofanew nephelometric technique tomeasure complement activation (1983) (0)
Direct visualisation of hepatitis B virus (HBV)-specific cytotoxic T cells with an human leucocyte antigen (HLA) class I peptide tetrameric complex allows a new insight into their actual frequency. (1998) (0)
500 AN INFLAMMATORY TH1 AND TH17 CYTOKINE PROFILE CHARACTERISES CELLULAR IMMUNE RESPONSES TO ALCOHOL DEHYDROGENASE IN PATIENTS WITH ALCOHOLIC LIVER DISEASE (2011) (0)
Appearance and evolution of liver kidney microsomal-1 autoimmune response investigated at epitope level (2001) (0)
The evolving potential of precision medicine in the management of autoimmune liver disease (2021) (0)
INTRAHEPATIC CD25+CD122-TCR gamma delta T CELLS IN PATIENTS WITH AUTOIMMUNE HEPATITIS PRODUCE MORE IL-17 THAN IFN-gamma (2009) (0)
PWE-041 Mannose binding lectin deficiency as a predictor of severity, disease progression and outcome following paracetamol-induced acute liver failure (2010) (0)
Chapter 6.2. Immune Function-related Liver Disease and ESPGHAN's Contribution to the Advancement of Science in the Last 3 Decades. (2018) (0)
Inflammatory Cytokines, IFNg, IL-17 and IL-23 Producing T Cells from Donor Livers Contribute to Acute Rejection after Liver Transplantation (2011) (0)
Hepatic expression oftumournecrosis factor-a in chronic hepatitis Bvirus infection (1994) (0)
232 EXPANDED CD14HI/CD16+ MONOCYTES IN ACUTE LIVER INJURY (ALI): ANGELS OR DEMONS? (2012) (0)
Can Pre-Core Mutation Status Help to Determine between the Stage of True Immune Tolerance and Early Immune Activity in HBeAg Positive Patients with Chronic Hepatitis B? (2016) (0)
Rapamycin favours the regulatory phenotype of antigen-specific Treg expanded from patients with autoimmune hepatitis by reducing the number of IFN gamma plus cells (2011) (0)
Immune-mediated diseases of the nervous system and eye (2009) (0)
BLOCK OF IFN gamma AND CO-CULTURE WITH SMDCS ENHANCE ANTIGEN-SPECIFIC T-REG SUPPRESSION ABILITY IN AUTOIMMUNE HEPATITIS TYPE 2 (2010) (0)
Soluble fas ligand levels during rejection after paediatric liver transplantation (1998) (0)
Short sequences of Pyruvate Dehydrogenase complex are key targets of AMA and probable templates for cross-reactivity in Primary Biliary Cirrhosis (2000) (0)
434 Detection of a new autoantibody in patients with chronic HCV infection (2006) (0)
[665] NOVEL ASSAY FOR THE DETECTION OF INTERLEUKIN-17: HIGH POSITIVITY IN PATIENTS WITH AUTOIMMUNE HEPATITIS (2007) (0)
631 Influence of the predisposing DRB1*08 allele and of the protective HLA-DRB1*11 allele over the expression of primary biliary cirrhosis-specific anti-mitochondrial and anti-nuclear reactivities (2006) (0)
Autoantibodies in Autoimmune Hepatitis (2014) (0)
Comparison of anti-cytochrome reactivity in autoimmune hepatitis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and autoimmune hepatitis type 2. (2001) (0)
CD86 EXPRESSION BY CD14H1MONOCYTES IS A PROMISING NOVEL BIOMARKER FOR OUTCOME IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE (2010) (0)
Unique Aspects of Autoimmune Hepatitis in Children (2007) (0)
Immunohistochemical characterization of the inflammatory cell infiltrate in fulminant hepatitis B (2002) (0)
CHARACTERISATION OF ANTI-LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IN CHILDRE WITH AUTOIMMUNE CHRONIC ACTIVE HEPATITIS (aCAH) (1986) (0)
433 Identification of a novel nuclear target antigen in hepatitis C and B virus chronic infections (2006) (0)
Two thirds of patients with sclerosing cholangitis fulfil the criteria for the diagnosis of autoimmune hepatitis. (2000) (0)
Use of eukaryotically expressed antigenic regions of cytochrome p4502d6 to differentiate lkm1 responses in autoimmune hepatitis type 2 and hcv infection (1999) (0)
Cross-reactive immunity between viral mimics and cytochrome P4502D6254–271, the immunodominant epitope of LKM-1 autoantibody is associated with a specific immunogenetic background (2001) (0)
Autoimmunity and the Liver: mechanistic insights (2016) (0)
High levels of hepatocyte growth factor predict the outcome of acute liver failure in children (2001) (0)
Effect of combined lamivudine and interferon alpha treatment on the T-cell response to HBV core peptides in patients with chronic hepatitis B virus infection (2002) (0)
P29 Reduced expression of Tim-3 renders Th1 and Th17 effector cells less amenable to T-reg control in autoimmune hepatitis (2011) (0)
Remission of Immune and Metabolic Changes in Non-Diabetic Identical Co-Twins of Insulin Dependent Diabetics (1986) (0)
934 DEFECTIVE CD39 EXPRESSION BY Tregs IN AUTOIMMUNE HEPATITIS PREVENTS SUPPRESSION OF IL17 PRODUCTION AND IS ASSOCIATED WITH IMPAIRED ATP-HYDROLYSIS (2013) (0)
MHC restriction to T-cell autoaggression: an emerging understanding of IDDM pathogenesis. (1998) (0)
High prevalence of antibodies to soluble liver antigen in children with bone marrow failure following non A-E acute liver failure (2005) (0)
Immunoglobulin levels in sle patients from malaysia (1988) (0)
A microbial mimic of the dominant T-cell autoepitope accounts for primary biliary cirrhosis-specific antibodies to a now mimicking microbial antigen (2005) (0)
Histological primary biliary cholangitis changes in patients with positive serology and normal alkaline phosphatase (2020) (0)
949 LOW CD39 EXPRESSION MARKS SEVERE REGULATORY T CELL IMPAIRMENT IN PATIENTS WITH AUTOIMMUNE SCLEROSING COLANGITIS (2012) (0)
Effect of CD4+CD25+ regulatory T cells on IL-4 producing CD8 T cells in autoimmune hepatitis. (2004) (0)
PROSPECTIVE MEASUREMENT OF CIRCULATING CYTOKINES IN AUTOIMMUNE HEPATITIS DURING IMMUNOSUPPRESSIVE TREATMENT (1999) (0)
P1203 : Effect of immunosuppressive drugs on the kinetics of co-inhibitory molecule expression and pro-inflammatory cytokine production by effector t cells in autoimmune hepatitis (2015) (0)
Autoimmune diseases in pediatric gastroenterology (2002) (0)
Heterogeneity ofliver/kidney microsomal antibody type1inautoimmune hepatitis andhepatitis C virus related liver disease (1995) (0)
THE ROLE OF LIVER INTERLEUKIN-17-PRODUCING GAMMA/DELTA T CELLS DURING HEPATIC REPERFUSION: 2364 (2010) (0)
Hepatocyte lysis by HBV-specific CD8 cells may not be the principal mechanism of viral control in acute hepatitis B. (1999) (0)
Peripheral blood and intra-islet lymphocyte subsets in non-obese diabetic mice (1994) (0)
PMO-137 Phenotypic and functional signature of CD4POSCD25HIGHCD127 low regulatory T-cells in autoimmune hepatitis (2012) (0)
683 LOW PRE-TREATMENT NUMBERS OF CD4+/PD1+ LYMPHOCYTES AND LOW HCV-SPECIFIC IL-10 PRODUCTION DURING THERAPY WITH PEGYLATED-INTERFERON+RIBAVIRIN PREDICT RESPONSE IN CHILDREN WITH CHRONIC HEPATITIS C (2010) (0)
53. AUTOANTIBODIES TO HEPATOCYTE MEMBRANE ANTIGENS IN ANTI‐LIVER KIDNEY MICROSOMAL POSITIVE CHRONIC LIVER DISEASE (1993) (0)
Clinical application ofnew technique that measures C4dforassessment ofactivation ofclassical complement pathway (2017) (0)
FRI-441-A novel heterozygous ABCB, RUNDC3B and ABCB1 deletion associated with severe cholestatic liver disease in adults (2019) (0)
910 EXPANSION OF HEPATIC MACROPHAGES IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE: WHERE DO THEY COME FROM AND WHAT IS THEIR ROLE? (2011) (0)
EVIDENCE OF IMPAIRED ANTIGEN NON-SPECIFIC BUT NORMAL ANTIGEN SPECIFIC SUPPRESSOR FUNCTION IN CHILDREN WITH AUTOMMUNE CHRONIC ACTIVE HEPATITIS (aCAH) (1986) (0)
Laminin and Diabetic Nephropathy (1986) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dr. D. Vergani?

Dr. D. Vergani is affiliated with the following schools:

King's College London

Dr. D. Vergani's Academic­Influence.com Rankings

Dr. D. Vergani's Degrees

Why Is Dr. D. Vergani Influential?

Dr. D. Vergani's Published Works

Published Works

What Schools Are Affiliated With Dr. D. Vergani?

Dr. D. Vergani's AcademicInfluence.com Rankings